Interstitial lung diseases
Thoracic oncology
Oral presentation
Clinical news in idiopathic interstitial pneumonias
Methods :
Imaging, Epidemiology, General respiratory patient care, Endoscopy and interventional pulmonology, Cell and molecular biology, Respiratory intensive care, Transplantation
10:45
Late Breaking Abstract - Prevalence and clinical significance of antinuclear antibody (ANA) in IPF: analysis from ESTAIR study
P. Wung(Sugar Land, United States)
COI
1
11:00
Four metre gait speed (4MGS) predicts mortality and hospitalisation in IPF
C. Nolan(Richmond, United Kingdom)
COI
2
11:15
A global perspective on acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF): results from an international survey
M. Kreuter(Mainz, Germany)
COI
3
11:30
Associations of interstitial lung abnormalities with physical function measures
G. Axelsson(Selfoss, Iceland)
COI
4
11:45
INTERSTITIAL LUNG DISEASE IN A LUNG CANCER SCREENING PROGRAM: PREVALENCE AND ASSOCIATION WITH CANCER.
A. Campo Ezquibela(Pamplona (Navarra), Spain)
COI
5
12:00
Longitudinal outcomes of patients enrolled in a phase Ib clinical trial of the Adipose Derived Stromal Cells-Stromal Vascular Fraction in Idiopathic Pulmonary Fibrosis
P. Ntolios(Alexandroupolis, Greece)
COI
6
12:15
Nintedanib plus sildenafil in patients with idiopathic pulmonary fibrosis (IPF): the INSTAGE trial
M. Kolb(Hamilton (ON), Canada)
COI
7
12:30
Contribution of mutations in genes of the surfactant system to idiopathic interstitial pneumonia (IIP)
N. Nathan(Paris, France)
COI
8
. . .
